Clostridioides difficile is the most prevalent pathogen of nosocomial diarrhea. In the United
States, over 450,000 cases of C. difficile infection (CDI), responsible for more than 29,000 …

Clostridioides difficile infection (CDI) remains a significant contributor to healthcare costs
and morbidity due to high rates of recurrence. Currently, available antibiotic treatment …

Clostridioides difficile is a gram-positive, spore-forming, obligate anaerobe that infects the
colon. C. difficile is estimated to cause nearly half a million cases in the United States …

Clostridioides difficile is one of the most important causes of healthcare-associated diarrhea.
The high incidence and recurrence rates of C. difficile infection, as well as its associated …

Clostridium difficile is mainly a nosocomial pathogen and is a significant cause of antibiotic-
associated diarrhea. It is also implicated in the majority of cases of pseudomembranous …

Clostridioides difficile (C. difficile) is a gram-positive, anaerobic spore-forming bacterium and
a major cause of antibiotic-associated diarrhea. Humans are naturally resistant to C. difficile …

Background Gut microbiota alterations and resulting changes in metabolites involved in
colonization resistance and host responses, including bile acids (BA) and short-chain fatty …

Clostridioides difficile infection (CDI) is a life-threatening disease caused by the Gram-
positive, opportunistic intestinal pathogen C. difficile. Despite the availability of antimicrobial …

Clostridioides difficile infection (CDI) is the leading cause of hospital-acquired diarrhea and
is common in the community. Both younger individuals who may be healthy otherwise and …

Clostridioides difficile infection (CDI) is a pressing health care issue due to the limited
effectiveness of current treatments and high recurrence rates. Current available antibiotic …